Target intelligence / Profile preview

FK506-binding protein 12 F36V-containing fusion protein (FKBP12(F36V) fusion protein)

Target
FKBP12(F36V) fusion protein
Molecular classification
Other, Receptor
01

Overview

FK506-binding protein 12 (FKBP12) F36V-containing fusion proteins are synthetic constructs designed for use in cell-based therapies to provide precise pharmacological control over cellular activities. This system utilizes a modified version of the human FKBP12 protein featuring a phenylalanine-to-valine substitution at position 36 (F36V), which creates a unique hydrophobic pocket. This pocket specifically binds to "bumped" synthetic ligands like rimiducid (AP1903) with high affinity, while avoiding interaction with endogenous wild-type FKBP12 or natural ligands like FK506 [1][2]. The most prominent application is the inducible Caspase-9 (iCasp9) safety switch, where the FKBP12(F36V) domain is fused to a truncated human Caspase-9. Upon administration of rimiducid, the drug acts as a chemical inducer of dimerization (CID), cross-linking two fusion proteins and triggering the apoptotic cascade to eliminate the engineered cells [1][3]. Beyond safety switches, these fusion proteins are also employed in inducible activation systems, such as the iMC (inducible MyD88/CD40) platform, to enhance the potency and persistence of chimeric antigen receptor (CAR) T cells in treating various cancers [4]. This technology allows clinicians to mitigate severe toxicities like graft-versus-host disease or cytokine release syndrome by selectively depleting the therapeutic cells. References: [1] Di Stasi A, et al. N Engl J Med. 2011;365(18):1673-1683. [2] Clackson T, et al. Proc Natl Acad Sci U S A. 1998;95(18):10437-10442. [3] Gargett T, Brown MP. Front Pharmacol. 2014;5:235. [4] Foster AE, et al. Mol Ther. 2017;25(5):1076-1085.

Other names
FKBP12v36FKBP(F36V)Inducible Caspase-9iCasp9Inducible MyD88/CD40iMCChemical inducer of dimerization (CID) system
02

Mechanism of action

Rimiducid acts as a bivalent chemical inducer of dimerization (CID) that binds to two FKBP12(F36V) domains simultaneously, bringing the attached effector proteins into close proximity to initiate downstream biological signaling or apoptosis [1][3].

03

Biological functions

Signal transductionApoptosisOther
04

Disease associations

CancerOther
05

Safety considerations

Immunogenicity of the engineered proteinBasal (leaky) activity in the absence of the inducer drugIncomplete clearance of the engineered cell population
06

Interacting drugs

Rimiducid

2 more in the full profile.

07

Biomarkers

FKBP12(F36V) transgene expressionCaspase-3 activationAnnexin V staining

Beyond the preview

Go deeper on FK506-binding protein 12 F36V-containing fusion protein (FKBP12(F36V) fusion protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FK506-binding protein 12 F36V-containing fusion protein (FKBP12(F36V) fusion protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call